PPAR inhibitor, Rosiglitazone, Purity ≥98%

Cat. No.: X24-08-YM421

PPAR inhibitor, Rosiglitazone, Purity ≥98%

Synonym: 122320-73-4; Avandia; BRL-49653; 5-[[4-[2-[Methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

  • MDL: MFCD00871760
  • CAS Number: 122320-73-4
  • Compound CID: 77999
Product Size
25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Rosiglitazone, soluble in DMSO and insoluble in water and ethanol, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting PPAR.
Molecular Weight
357.4
Molecular Formula
C18H19N3O3S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 65 mg/mL (181.85 mM); Water: insoluble; Ethanol: insoluble; In vivo: 4% DMSO + 30% PEG 300 + 5% Tween 80 + ddH2O, 4 mg/mL
Applications
Rosiglitazone is a metabolism inhibitor that can be used for its ability to improve insulin sensitivity and help control blood glucose levels.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0